Call Us @ 0172 - 4680800 | info@indswift.com | NETWORKS | NSE - BSE

Investors

UNAUDITED FINANCIAL RESULTS  FOR THE QUARTER ENDED JUNE'2017
(Rs. In lacs.)
PARTICULARS UNAUDITED
Quarter
30.06.17
UNAUDITED
Quarter
30.06.16
     
REVENUE  FROM OPERATIONS 5260.81 6157.46
OTHER INCOME 104.17 42.86
TOTAL REVENUE 5364.98 6200.32
EXPENSES    
COST OF MATERIALS CONSUMED 2729.20 2109.18
PURCHASE OF STOCK IN TRADE 859.75 1329.47
CHANGE IN INVENTORIES OF FINISHED GOODS,WORK IN PROGRESS -513.93 211.72
AND STOCK IN TRADE    
EMPLOYEES BENEFIT EXPENSES 1107.95 984.32
FINANCE COST 303.58 435.63
DEPRECIATION/AMORTISATION 859.59 887.77
OTHER EXPENSES 1474.85 2802.58
TOTAL EXPENSES 6820.99 8760.67
PROFIT (LOSS) BEFORE EXCEPTIONAL ITEMS AND TAX -1456.01 -2560.35
EXCEPTIONAL ITEMS 0.00 0.00
PROFIT (LOSS) BEFORE EXTRAORDINARY  ITEMS AND TAX 0.00 0.00
EXTRAORDINARY ITEM 0.00 0.00
PROFIT (LOSS) BEFORE TAX -1456.01 -2560.35
TAX EXPENSES:-    
CURRENT TAX 0.00 0.00
DEFFERRED TAX 0.00 0.00
MAT CREDIT ENTITLEMENT 0 0.00
PROFIT(LOSS) FOR THE PERIOD FROM CONTINUING OPERATIONS -1456.01 -2560.35
PROFIT(LOSS)  FROM DISCONTINUING OPERATIONS 0.00 0.00
TAX EXPENSES OF DISCONTINUING OPERATIONS 0.00 0.00
PROFIT(LOSS)  FROM DISCONTINUING OPERATIONS (AFTER TAX) 0.00 0.00
PROFIT(LOSS) FOR THE PERIOD -1456.01 -2560.35
OTHER COMPREHENSIVE INCOME    
ITEMS THAT WILL NOT BE CLASSIFIED TO PROFIT & LOSS 0.00 0.13
ITEMS THAT WILL BE CLASSIFIED TO PROFIT & LOSS 0.00 0.00
TOTAL OTHER COMPREHENSIVE INCOME NET OF INCOME TAX 0.00 -2560.22
TOTAL COMPREHENSIVE INCOME FOR THE PERIOD -1456.01 -2560.22
PAID UP EQUITY SHARE CAPITAL Rs. 2/- 1083.29 1006.94
EARNING PER SHARE RS. 2/- EACH (Not Annulized)    
BASIC -2.69 -5.08
DILUTED  -2.69 -5.08
Notes:-
1:- During this quarter some banks/ Assets Reconstruction Companies (ARC's) have not charged interest due to NPA status of account on cash credit,Term Loans,Working Capital Term Loans and Funded Interest Term Loans accounts. Also some banks/ARC's have not provided bank statements due to which interest charged figures are not available, Hence The accrued liability on account of the same amounting to Rs. 3399.28 lacs. has not been provided in books of accounts.
2:- Interest on fixed deposit during this quarter,(amount not ascertained) has not been provided in accounts as the company has filed application with National Company Law Tribunal (NCLT) for again restructuring the repayment schedule and the matter is subjudice with NCLT.
3:- Other expenses for this quarter include Rs. 374.14 lacs being the stock written off by the company on account of expired/spoilage/ non moving stocks of raw material being not realizable in normal course of business.
4:- The Company has First time adopted IND-AS with effect from 1st April 2017, with the transition date of 1st April 2016, The unaudited financial results have been prepared by the company in accordance with the Companies (Indian Accounting Standared) Rules 2015 (IND-AS) prescribed under section 133 of the companies act 2013 and other recognised accounting practices and policies to the extent applicable.
5:- The statement does not include Ind-AS compliant results for the preceding quarter and previous year ended 31st March 2017 as the same is not madatory as per SEBI circular dated 5th July 2016.
6:- Impairment Loss, if any, will be accounted for at the year end.
7:- Deferred Tax Asset/Liability will be accounted for at the year end.
8:- Reconciliation of Net Profit/Loss for the quarter ended June 30,2016 under India GAAP (Previous GAAP) and Ind AS is as under:
Quarter ended June.16
(Rs. In Lacs)
Net Profit/Loss for the quarter as per Previous GAAP -2438.31
Fare Value Adjustement of Investments through Profit & Loss -122.04
Net Profit/Loss for the quarter as per Ind AS -2560.35
Adjustement of other expenses in other comprehensive Income 0.13
Total Comprehensive Income for the Period -2560.22
9:- The Company is exclusively in Pharmaceutical business.
10:- Previous period figures have been re-grouped/Re-arranged where ever necessary.
11:- The above financial results have been reviewed by the Audit Committee and approved  by the Board of Directors at their respective meetings held on 14th Sept 2017.